Serine protease inhibitors inhibit superoxide release and adherence in human neutrophils stimulated by granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-α

International Journal of Hematology

Volumn 77, Issue 3, 2003, Pages 253-258

  Zhou, Yue Min ^a   Kutsuna, Haruo ^a   Suzuki, Kenichi ^a   Hato, Fumihiko ^a   Kitagawa, Seiichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adherence; Cytokine; Neutrophil; Serine protease; Superoxide

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ADHESION; CONCENTRATION RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; NEUTROPHIL; PROTEINASE INHIBITION;

EID: 0141569445     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02983782     Document Type: Article

References (22)

1. Kitagawa S, Yuo A, Souza LM, Saito M, Miura Y, Takaku F. Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide. Biochem Biophys Res Commun. 1987;144:1143-1146.
2. Suzuki K, Hino M, Hato F, et al. Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-α. Blood. 1999;93:341-349.
3. Suzuki K, Hino M, Kutsuna H, et al. Selective activation of p38 mitogen-activated protein kinase cascade in human neutrophils stimulated by IL-1β. J Immunol. 2001;167:5940-5947.
4. Suzuki K, Hasegawa T, Sakamoto C, et al. Cleavage of mitogen-activated protein kinases in human neutrophils undergoing apoptosis: role in decreased responsiveness to inflammatory cytokines. J Immunol. 2001;166:1185-1192.
5. Kitagawa S, Takaku F, Sakamoto S. Possible involvement of proteases in superoxide production by human polymorphonuclear leukocytes. FEBS Lett. 1979;99:275-278.
6. Kitagawa S, Takaku F, Sakamoto S. Serine protease inhibitors inhibit superoxide production by human polymorphonuclear leukocytes and monocytes stimulated by various surface active agents. FEBS Lett. 1979;107:331-334.
7. Kitagawa S, Takaku F, Sakamoto S. Evidence that proteases are involved in superoxide production by human polymorphonuclear leukocytes and monocytes. J Clin Invest. 1980;65:74-81.
8. King CH, Goralnik CH, Kleinhenz PJ, Marino JA, Sedor JR, Mahmoud AA. Monoclonal antibody characterization of a chymotrypsin-like molecule on neutrophil membrane associated with cellular activation. J Clin Invest. 1987;79:1091-1098.
9. Kilpatrick L, Johnson JL, Nickbarg EB, et al. Inhibition of human neutrophil superoxide generation by alpha 1-antichymotrypsin. J Immunol. 1991;146:2388-2393.
10. Gervaix A, Kessels GC, Suter S, Lew PD, Verhoeven AJ. The chymotrypsin inhibitor carbobenzyloxy-leucine-tyrosine-chloromethylketone interferes with the neutrophil respiratory burst mediated by a signaling pathway independent of PtdInsP2 breakdown and cytosolic free calcium. J Immunol. 1991;147:1912-1919.
11. Bucurenci N, Blake DR, Chidwick K, Winyard PG. Inhibition of neutrophil superoxide production by human plasma alpha 1-antitrypsin. FEBS Lett. 1992;300:21-24.
12. Schuster MG, Enriquez PM, Curran P, Cooperman BS, Rubin H. Regulation of neutrophil superoxide by antichymotrypsin-chymotrypsin complexes. J Biol Chem. 1992;267:5056-5059.
13. Takahashi T, Hato F, Yamane T, et al. Increased spontaneous adherence of neutrophils from type 2 diabetic patients with overt proteinuria. Diabetes Care. 2000;23:417-418.
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-268.
15. Nathan C, Srimal S, Farber C, et al. Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins. J Cell Biol. 1989;109:1341-1349.
16. Yuo A, Kitagawa S, Ohsaka A, Saito M, Takaku F. Stimulation and priming of human neutrophils by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: qualitative and quantitative differences. Biochem Biophys Res Commun. 1990;171:491-497.
17. Coffer PJ, Geijsen N, M'rabet L, et al. Comparison of the roles of mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase signal transduction in neutrophil effector function. Biochem J. 1998;329:121-130.
18. Sakamoto C, Suzuki K, Hato F, et al. Anti-apoptotic effect of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and cyclic AMP on human neutrophils: protein synthesis-dependent and protein synthesis-independent mechanisms and the role of the Janus kinase-STAT pathway. Int J Hematol. 2003;77:60-70.
19. Hasegawa T, Suzuki K, Sakamoto C, et al. Expression of the inhibitor of apoptosis (IAP) family members in human neutrophils: up-regulation of cIAP2 by granulocyte colony-stimulating factor and overexpression of cIAP2 in chronic neutrophilic leukemia. Blood. 2003;101:1164-1171.
20. - generation in response to tumor necrosis factor-α, and antibodies against CD18 and CD11a: evidence for a common and unique pattern of sensitivity to wortmannin and protein tyrosine kinase inhibitors. Biochem Biophys Res Commun. 1993;190:935-940.
21. Nakatani K, Takeshita S, Tsujimoto H, Kawamura Y, Sekine I. Inhibitory effect of serine protease inhibitors on neutrophil-mediated endothelial cell injury. J Leukoc Biol. 2001;69:241-247.
22. Takahashi T, Hato F, Yamane T, et al. Activation of human neutrophil by cytokine-activated endothelial cells. Circ Res. 2001;88:422-429.